1174. Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Catch-up Vaccination Regimens of V114 in Healthy Infants, Children, and Adolescents (PNEU–PLAN)

BACKGROUND: Despite widespread use of pneumococcal conjugate vaccines (PCVs) in children, morbidity and mortality caused by pneumococcal disease (PD) remain high, in part due to the emergence of disease caused by non-vaccine serotypes (STs). In addition, many children do not receive the recommended...

Descripción completa

Detalles Bibliográficos
Autores principales: Banniettis, Natalie, Wysocki, Jacek, Szenborn, Leszek, Phongsamart, Wanatpreeya, Pitisuttithum, Punnee, Rämet, Mika, Dagan, Ron, Good, Lori, Papa, Melanie, Shi, Yaru, Musey, Luwy, Bickham, Kara, Tamms, Gretchen, McFetridge, Richard, Lupinacci, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643899/
http://dx.doi.org/10.1093/ofid/ofab466.1367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643899/
http://dx.doi.org/10.1093/ofid/ofab466.1367

Ejemplares similares